Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
P62269
UPID:
RS18_HUMAN
Alternative names:
40S ribosomal protein S18; Ke-3
Alternative UPACC:
P62269; P25232; Q5SUJ3; Q6IPF8
Background:
Small ribosomal subunit protein uS13, also known as 40S ribosomal protein S18 and Ke-3, plays a pivotal role in the cell as a component of the small ribosomal subunit. The ribosome, a large ribonucleoprotein complex, is essential for protein synthesis, translating mRNA into polypeptide chains.
Therapeutic significance:
Understanding the role of Small ribosomal subunit protein uS13 could open doors to potential therapeutic strategies. Its critical function in protein synthesis makes it a potential target for interventions in diseases where protein production is dysregulated.